Synexus’s New Phase IV Clinical Trial Model Increases Number of Doctors Involved Whilst Cutting Costs and Time

MANCHESTER, England--(BUSINESS WIRE)--Synexus® – the world’s largest multi-national company specialising in the recruitment and running of late-stage clinical trials – is extending the scope of its studies to include Phase IV trials following the recent running of successful Phase IV studies for major pharmaceutical companies.